COMPARISON STUDY INJECTION HEAVY BUPIVACAINE 0.5% VS INJECTION HEAVY BUPIVACAINE 0.5% WITH FENTANYL IN LOWER ABDOMINAL AND LOWER LIMB SURGERIES
Not Applicable
- Registration Number
- CTRI/2023/06/054076
- Lead Sponsor
- Anurag Agarwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Patients of age 18-60 years
2. American society of Anaesthesiologist (ASA) physical status I/II
3. Planned for elective surgery under Spinal anaesthesia.
Exclusion Criteria
1. Patients refusing consent
2. Patients having local sepsis at site where spinal anesthesia is to given.
3. Patients with known bleeding or coagulation disorders
4. Patients with spinal deformity
5. Patients with Cardiopulmonary diseases
6. Patients with Neurological or psychiatric disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hyperbaric Bupivacaine 0.5% with Fentanyl in Spinal Anesthesia for Lower Abdominal & Lower Extremity Surgeries found to have longer duration of sensory and motor blockage then hyperbaric bupivacaine 0.5% aloneTimepoint: Primary outcome assessed in 6 weeks
- Secondary Outcome Measures
Name Time Method Quality of subarachnoid block, hemodynamic stability, <br/ ><br>perioperative analgesia in patients undergoing for Lower <br/ ><br>Abdominal & Lower Extremity Surgeries are better in patients receiving bupivacine 0.5% with fentanyl as compared to patients receiving bupivacine 0.5% alone.Timepoint: Secondary outcome was assessed in 8 weeks